<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> is a <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological disorder</z:e> whose symptoms include <z:hpo ids='HP_0010864'>severe mental retardation</z:hpo>, loss of motor coordination, and <z:hpo ids='HP_0002360'>sleep disturbances</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The disease is caused by a loss of function of UBE3A, which encodes a HECT-domain ubiquitin ligase </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we generate a Drosophila model for the disease </plain></SENT>
<SENT sid="3" pm="."><plain>The results of several experiments show that the functions of human UBE3A and its fly counterpart, dube3a, are similar </plain></SENT>
<SENT sid="4" pm="."><plain>First, expression of Dube3a is enriched in the Drosophila <z:mp ids='MP_0008912'>nervous</z:mp> system, including mushroom bodies, the seat of learning and memory </plain></SENT>
<SENT sid="5" pm="."><plain>Second, we have generated dube3a null mutants, and they appear <z:mpath ids='MPATH_458'>normal</z:mpath> externally, but display abnormal locomotive behavior and circadian rhythms, and defective long-term memory </plain></SENT>
<SENT sid="6" pm="."><plain>Third, flies that overexpress Dube3a in the <z:mp ids='MP_0008912'>nervous</z:mp> system also display locomotion defects, dependent on the ubiquitin ligase activity </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, missense mutations in UBE3A alleles of <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> patients alter amino acid residues conserved in the fly protein, and when introduced into dube3a, behave as loss-of-function mutations </plain></SENT>
<SENT sid="8" pm="."><plain>The simplest model for <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> is that in the absence of UBE3A, particular substrates fail to be ubiquitinated and proteasomally degraded, accumulate in the brain, and interfere with brain function </plain></SENT>
<SENT sid="9" pm="."><plain>We have generated flies useful for genetic screens to identify Dube3a substrates </plain></SENT>
<SENT sid="10" pm="."><plain>These flies overexpress Dube3a in the eye or wing and display morphological abnormalities, dependent on the critical catalytic cysteine </plain></SENT>
<SENT sid="11" pm="."><plain>We conclude that dube3a mutants are a valid model for <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e>, with great potential for identifying the elusive UBE3A substrates relevant to the disease </plain></SENT>
</text></document>